Last reviewed · How we verify
Yellow fever vaccine, Chumakov Institute — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Yellow fever vaccine, Chumakov Institute (Yellow fever vaccine, Chumakov Institute) — Epicentre.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Yellow fever vaccine, Chumakov Institute TARGET | Yellow fever vaccine, Chumakov Institute | Epicentre | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Yellow fever vaccine, Chumakov Institute CI watch — RSS
- Yellow fever vaccine, Chumakov Institute CI watch — Atom
- Yellow fever vaccine, Chumakov Institute CI watch — JSON
- Yellow fever vaccine, Chumakov Institute alone — RSS
Cite this brief
Drug Landscape (2026). Yellow fever vaccine, Chumakov Institute — Competitive Intelligence Brief. https://druglandscape.com/ci/yellow-fever-vaccine-chumakov-institute. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab